Table 4 Comparative costs (US$) for first-line treatment of MCRC with XELOX and FOLFOX4 from a societal perspective

Scheduled costs per cycle

Treatment cost

2,046 (325)

2,152 (307)

Patient time cost

51 (-)*

265(-)*

Patient travel cost

42 (-)*

33 (-)*

Total scheduled cost per cycle

2,139

2,450

Total scheduled cost per patient

15,544

22,539

Other unscheduled costs

Treatment cost

240 (364)

421 (890)

Patient time cost

59 (-)*

99 (-)*

Patient travel cost

17 (-)*

14 (-)*

Total unscheduled cost per cycle

315

534

Total unscheduled cost per patient

2,292

4,915

Total cost per patient

17,836

27,455